Back to
UBS Group AG
SKYE9 quarters
Position history for
UBS Group AG's holdings in SKYE BIOSCIENCE INC
Yes. Ubs holds 73,800 shares of SKYE (Skye Bioscience), worth $51,143, as of its Q2 2026 13F filing. It increased the position by 28,038 shares (+61.3%) from Q1 2026. Ubs has held SKYE in every 13F on record since Q2 2024, 9 quarterly filings.
Current Value
$51,143
Current Shares
73,800
Total Value Change
+$9,091
Total Shares Change
+68,550
Quarter-by-Quarter History
Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., BAKER BROS. ADVISORS LP